Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents (includes restricted cash of $0 and $1,855 at December 31, 2024 and 2023, respectively)	$ 111,835	$ 136,964
Accounts receivable, net of allowances of $783 and $1,118 at December 31, 2024 and 2023, respectively	15,742	18,264
Prepaid expenses	4,499	6,067
Other current assets	3,052	1,787
Total current assets	135,128	163,082
Property and equipment, net	15,735	18,880
Operating lease right-of-use assets	2,351	10,132
Intangible assets, net	1,970	8,375
Other assets	4,507	3,851
Total assets	159,691	204,320
Current liabilities
Accounts payable	7,928	6,875
Accrued employee expenses	4,892	6,667
Operating lease liabilities, current	2,964	3,240
Accrued expenses and other current liabilities	17,109	12,196
Total current liabilities	32,893	28,978
Operating lease liabilities, net of current portion	8,313	11,169
Other liabilities	348	3,958
Total liabilities	41,554	44,105
Commitments and contingencies
Stockholders’ Equity
Preferred stock — $0.0001 par value; 20,000,000 shares authorized at December 31, 2024 and 2023, respectively; no shares issued and outstanding at December 31, 2024 and 2023	0	0
Common stock — $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2024 and 2023; 87,190,136 and 91,091,541 shares issued and outstanding at December 31, 2024 and 2023, respectively	9	9
Additional paid-in capital	711,474	722,504
Accumulated deficit	(593,346)	(562,298)
Total stockholders’ equity	118,137	160,215
Total liabilities and stockholders’ equity	$ 159,691	$ 204,320